Navigation Links
Using hair to manage HIV/AIDS and predict treatment success
Date:3/3/2009

HIV clinical care of measuring hemoglobin A1C, the method used in diabetes to monitor average blood glucose levels," said study co-investigator, Ruth M. Greenblatt, MD, UCSF professor of clinical pharmacy and principal investigator of the Women's Interagency HIV study.

Researchers took 10 strands of hair from patients on HIV therapy from the back of the head. They cut the hair sample close to the scalp underneath the top layer of hair, marked the part farthest from the scalp with tape and wrapped the strands in aluminum foil. The sample was then stored at room temperature in a plastic bag until it was analyzed.

"This is a painless, bloodless, biohazard-free, method of collecting a stable specimen from HIV patients that may allow for the monitoring of levels of antiretroviral drugs absorbed over time and the prediction of treatment success," said Gandhi. "Our next step is to test this method in resource-limited settings where blood collection and viral load monitoring may be expensive and difficult. Not only could this method help in measuring pill-taking, but its strong correlation with viral suppression could allow its use as an inexpensive, non-invasive method of monitoring treatment success in particularly challenging settings."

Researchers from this group are also collaborating with public health researchers in testing hair to monitor pill-taking in clinical trials of single or dual antiretrovirals in high risk, HIV negative individuals to prevent infection with HIV (pre-exposure prophylaxis, known as PrEP, trials).

The 224 patients in this study were drawn from the Women's Interagency HIV study, an ongoing multi-center, prospective study of HIV-infected and at risk uninfected women established in 1994.

"Women taking antiretroviral medications may have more adverse events than men taking these regimens. The safety trials of these medications were conducted in trials consisting largely of men, and the highest tole
'/>"/>

Contact: Jeff Sheehy
jsheehy@ari.ucsf.edu
415-597-8165
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Milestone achieved toward production of malaria treatment using synthetic biology and fermentation
2. MIT: Using touch to help deaf people
3. Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test
4. Biological control of tropical weeds using arthropods
5. Defying the disaster: Researcher explores resilient housing
6. Link between unexploded munitions in oceans and cancer-causing toxins determined
7. Singapore research organisations team up to advance drug discovery using brain tumor stem cells
8. While focusing on heart disease, researchers discover new tactic against fatal muscular dystrophy
9. Mayo Clinic researchers suspect a novel gene is causing restless legs syndrome in a large family
10. Cancer-causing gene discovery suggests new therapies
11. Warmer climate causing huge increase in tree mortality across the West
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2015)... 17, 2015 MedNet Solutions , ... clinical study management systems, is pleased to announce ... ARENA,s Outsourcing in Clinical Trials Southeast conference – ... an excellent forum for MedNet to showcase ... software-as-a-service (SaaS) eClinical technology platform. We ...
(Date:3/12/2015)... Va. , March 12, 2015 IriTech, ... and a member of the Texas Instruments Design Network, ... Naidu has demonstrated its IriShield USB MK2120U device ... scanning facility for pension distribution. The ... assembled to be marketed in India ...
(Date:3/11/2015)... 11, 2015 Research and Markets ( ... "Access Control Market by Product, Application & By Geography ... to their offering. , This report predicts ... $10.4 billion by 2020, with an estimated CAGR of ... the products types such as contact cards & readers, ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
... cause of cardiovascular disease, research from the Sahlgrenska Academy at ... body,s obesity hormones adiponectin - are also linked to ... skeleton is more than just bones, vertebrae and joints. In ... to our brain, our muscles and our fatty tissue. Stem ...
... Discovering new treatments and battling dangerous infections are the ... genetic disorder cystic fibrosis with projects funded by a ... support from a $110,000 grant from Hunt for a ... Institute, expand the relationship between the two organizations. Funding ...
... 2011) Policy decisions and poor management have substantially ... security, according to an article available today in the ... published by SAGE. The article calls into question media ... for the decline. , According to George Mason University ...
Cached Biology News:4 projects target cystic fibrosis with Hunt for a Cure funds 2Structure, not scientists to blame for Los Alamos failings 2Structure, not scientists to blame for Los Alamos failings 3
(Date:3/27/2015)... Earlier this year, the Capillus272Pro™ received FDA ... adult men and women with androgenic alopecia (AGA) having ... IIa-V and Fitzpatrick Classification of Skin phototypes I-IV. ... and under-deliver, FDA Clearance underscores the safety and efficacy ... than 80 million men and women who suffer with ...
(Date:3/27/2015)... , March 27, 2015   SurePure, Inc ... photopurification, announced today that the Company has completed ... continued trading of SurePure ("SURP") securities on OTCQB, ... for entrepreneurial and development stage companies. ... standards and eligibility requirements designed to improve marketplace ...
(Date:3/27/2015)... 27, 2015  CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , today ... ended December 31, 2014.  The Company ... per share, for the three months ended December 31, ...
(Date:3/26/2015)... 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or ... dealing with certain matters, including the appointment of auditors, ... March 26, 2015 (the "Meeting") was adjourned, as previously ... at 11:00 a.m. ( Toronto time). ... from that previous disclosed. The Meeting will reconvene at ...
Breaking Biology Technology:Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2SurePure Completes Verification and Approved for Trading on the OTCQB Marketplace 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 2CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 3CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 4CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 5CASI Pharmaceuticals Reports 2014 Fourth Quarter And Full Year Financial Results 6SQI Diagnostics Inc. Announces Adjournment of Meeting 2
... SAN DIEGO, Dec. 15, 2010 Ocera Therapeutics, ... studies evaluating the safety and pharmacokinetics of OCR-002 ... with liver cirrhosis.  OCR-002 recently received Orphan Drug ... States Food and Drug Administration for the treatment ...
... Dec. 14, 2010 Reportlinker.com announces that a ... catalogue: 2010 Membrane and Separation ... FOREWORD  ... as the myriad applications they are called upon ...
... Cylex Incorporated® today announced that the Centers ... tripled the reimbursement for ImmuKnow® , the immune ... cell-mediated immune response in populations undergoing immunosuppressive therapy ... in a time when the overall CMS clinical ...
Cached Biology Technology:Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy 2Ocera Therapeutics Completes First in Human Studies with OCR-002 for the Treatment of Hyperammonemia and Hepatic Encephalopathy 3Reportlinker Adds 2010 Membrane and Separation Technology Research Review 2Reportlinker Adds 2010 Membrane and Separation Technology Research Review 3Reportlinker Adds 2010 Membrane and Separation Technology Research Review 4Reportlinker Adds 2010 Membrane and Separation Technology Research Review 5Reportlinker Adds 2010 Membrane and Separation Technology Research Review 6Reportlinker Adds 2010 Membrane and Separation Technology Research Review 7Reimbursement Rate Nearly Tripled for Cylex's ImmuKnow® Assay 2
... Aminopropylsilane is perhaps the ... chemistry for microarray experiments. ... for Microarrays provide a ... for printing PCR products ...
Designed for use with any of the Agencourt kits in tube format....
... This CLS number is a new ... Cornings product number. If showing no ... old Sigma-Aldrich number (Z71,405-4) or contact ... diam. 60 mm volume diam. ...
... DAPI (4,6-diamidine-2-phenylindole, dihydrochloride) is a ... nucleus blue in color. The ... contrast to red fluorochromes such ... or R-Phycoerythrin. DAPI can be ...
Biology Products: